Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Exact Sciences Analyst Ratings and Price Targets | NASDAQ:EXAS | Benzinga
Exact Sciences Corp has a consensus price target of $73.08 based on the ratings of 27 analysts. The high is $90 issued by Bernstein on October 30, 2024. The low is $52 issued by RBC Capital on March 13, 2025. The 3 most-recent analyst ratings were released by RBC Capital, Piper Sandler, and Scotiabank on March 13, 2025, February 26, 2025, and February 24, 2025, respectively. With an average price target of $65 between RBC Capital, Piper Sandler, and Scotiabank, there's an implied 38.36% upside for Exact Sciences Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Piper Sandler
Scotiabank
B of A Securities
Barclays
1calculated from analyst ratings
Analyst Ratings for Exact Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 10.69% | RBC Capital | Gerard Cassidy72% | → $52 | Initiates | → Sector Perform | Get Alert |
| 02/26/2025 | Buy Now | 49% | Piper Sandler | David Westenberg59% | $75 → $70 | Maintains | Overweight | Get Alert |
| 02/24/2025 | Buy Now | 55.39% | Scotiabank | Sung Ji Nam46% | $70 → $73 | Maintains | Sector Outperform | Get Alert |
| 02/20/2025 | Buy Now | 38.36% | B of A Securities | Derik De Bruin84% | $72 → $65 | Maintains | Buy | Get Alert |
| 02/20/2025 | Buy Now | 38.36% | Barclays | Luke Sergott50% | $70 → $65 | Maintains | Overweight | Get Alert |
| 01/23/2025 | Buy Now | 49% | Barclays | Luke Sergott50% | → $70 | Initiates | → Overweight | Get Alert |
| 01/13/2025 | Buy Now | 38.36% | Benchmark | Bruce Jackson42% | $65 → $65 | Reiterates | Buy → Buy | Get Alert |
| 12/13/2024 | Buy Now | 53.26% | B of A Securities | Derik De Bruin84% | $75 → $72 | Maintains | Buy | Get Alert |
| 11/26/2024 | Buy Now | 83.06% | TD Cowen | Dan Brennan66% | $82 → $86 | Maintains | Buy | Get Alert |
| 11/26/2024 | Buy Now | 59.64% | BTIG | Mark Massaro72% | $65 → $75 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | 59.64% | Piper Sandler | David Westenberg59% | $85 → $75 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 59.64% | Citigroup | Patrick Donnelly80% | $80 → $75 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 80.93% | Jefferies | Brandon Couillard71% | $84 → $85 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 38.36% | BTIG | Mark Massaro72% | $82 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 42.61% | Stifel | Daniel Arias66% | $82 → $67 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 59.64% | Canaccord Genuity | Kyle Mikson34% | $95 → $75 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 74.54% | TD Cowen | Dan Brennan66% | $90 → $82 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 38.36% | Goldman Sachs | Matthew Sykes66% | $75 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 27.71% | Evercore ISI Group | Vijay Kumar53% | $80 → $60 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 38.36% | Craig-Hallum | Alex Nowark61% | $82 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 38.36% | Benchmark | Bruce Jackson42% | $67 → $65 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 42.61% | Baird | Catherine Schulte68% | $70 → $67 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | 91.57% | Bernstein | Eve Burstein45% | $75 → $90 | Maintains | Outperform | Get Alert |
| 10/29/2024 | Buy Now | 102.21% | Canaccord Genuity | Kyle Mikson34% | $75 → $95 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | 70.29% | Evercore ISI Group | Vijay Kumar53% | $72 → $80 | Maintains | Outperform | Get Alert |
| 09/26/2024 | Buy Now | — | Raymond James | Andrew Cooper54% | — | Reiterates | → Market Perform | Get Alert |
| 09/13/2024 | Buy Now | 59.64% | Canaccord Genuity | Kyle Mikson34% | $75 → $75 | Maintains | Buy | Get Alert |
| 09/12/2024 | Buy Now | 80.93% | Piper Sandler | David Westenberg59% | $75 → $85 | Maintains | Overweight | Get Alert |
| 08/27/2024 | Buy Now | 59.64% | Wells Fargo | Brandon Couillard71% | → $75 | Initiates | → Overweight | Get Alert |
| 08/01/2024 | Buy Now | 42.61% | Benchmark | Bruce Jackson42% | $91 → $67 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | 74.54% | Stifel | Daniel Arias66% | $100 → $82 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | 59.64% | Goldman Sachs | Matthew Sykes66% | $88 → $75 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 53.26% | Evercore ISI Group | Vijay Kumar53% | $80 → $72 | Maintains | Outperform | Get Alert |
| 06/27/2024 | Buy Now | 49% | BTIG | Mark Massaro72% | $80 → $70 | Maintains | Buy | Get Alert |
| 06/27/2024 | Buy Now | 49% | Scotiabank | Sung Ji Nam46% | → $70 | Initiates | → Sector Outperform | Get Alert |
| 06/26/2024 | Buy Now | 49% | BTIG | Mark Massaro72% | $80 → $70 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 70.29% | BTIG | Mark Massaro72% | $85 → $80 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 80.93% | Canaccord Genuity | Kyle Mikson34% | $90 → $85 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 70.29% | Citigroup | Patrick Donnelly80% | $100 → $80 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 112.86% | Citigroup | Patrick Donnelly80% | → $100 | Maintains | Buy | Get Alert |
| 02/22/2024 | Buy Now | 91.57% | Canaccord Genuity | Kyle Mikson34% | $100 → $90 | Maintains | Buy | Get Alert |
| 01/02/2024 | Buy Now | 93.7% | Benchmark | Bruce Jackson42% | → $91 | Upgrade | Hold → Buy | Get Alert |
| 12/14/2023 | Buy Now | 91.57% | Guggenheim | Subbu Nambi37% | → $90 | Initiates | → Buy | Get Alert |
| 12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel71% | — | Initiates | → Outperform | Get Alert |
| 11/03/2023 | Buy Now | 91.57% | Goldman Sachs | Matthew Sykes66% | $100 → $90 | Maintains | Buy | Get Alert |
| 10/16/2023 | Buy Now | 70.29% | Piper Sandler | David Westenberg59% | $90 → $80 | Maintains | Overweight | Get Alert |
| 10/10/2023 | Buy Now | 91.57% | Piper Sandler | David Westenberg59% | → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 09/28/2023 | Buy Now | 76.67% | Bernstein | Eve Burstein45% | → $83 | Initiates | → Outperform | Get Alert |
| 08/08/2023 | Buy Now | 91.57% | Piper Sandler | David Westenberg59% | $80 → $90 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | 134.14% | Jefferies | Brandon Couillard71% | $100 → $110 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 91.57% | Credit Suisse | Dan Leonard55% | $75 → $90 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | 157.56% | Baird | Catherine Schulte68% | $99 → $121 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | — | Benchmark | Bruce Jackson42% | — | Downgrade | Buy → Hold | Get Alert |
| 07/24/2023 | Buy Now | 134.14% | Goldman Sachs | Matthew Sykes66% | $85 → $110 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | 134.14% | Goldman Sachs | Matthew Sykes66% | $85 → $110 | Maintains | Buy | Get Alert |
| 06/23/2023 | Buy Now | 144.79% | Canaccord Genuity | Kyle Mikson34% | $92 → $115 | Maintains | Buy | Get Alert |
| 06/22/2023 | Buy Now | 176.71% | Citigroup | Patrick Donnelly80% | $100 → $130 | Maintains | Buy | Get Alert |
| 06/22/2023 | Buy Now | 104.34% | Benchmark | Bruce Jackson42% | → $96 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | 80.93% | Stifel | Daniel Arias66% | → $85 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | 95.83% | Canaccord Genuity | Kyle Mikson34% | → $92 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | Buy Now | 112.86% | Jefferies | Brandon Couillard71% | $82 → $100 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 112.86% | Citigroup | Patrick Donnelly80% | $90 → $100 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 74.54% | Jefferies | Brandon Couillard71% | $72 → $82 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 87.31% | B of A Securities | Derik De Bruin84% | $80 → $88 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 59.64% | Credit Suisse | Dan Leonard55% | $70 → $75 | Maintains | Neutral | Get Alert |
| 05/10/2023 | Buy Now | 110.73% | Baird | Catherine Schulte68% | $92 → $99 | Maintains | Outperform | Get Alert |
| 05/10/2023 | Buy Now | 80.93% | Craig-Hallum | Alex Nowark61% | $55 → $85 | Upgrade | Hold → Buy | Get Alert |
| 05/05/2023 | Buy Now | 55.39% | UBS | Elizabeth Garcia67% | → $73 | Initiates | → Neutral | Get Alert |
| 03/15/2023 | Buy Now | 66.03% | Benchmark | Bruce Jackson42% | $54 → $78 | Maintains | Buy | Get Alert |
| 03/09/2023 | Buy Now | 91.57% | Citigroup | Patrick Donnelly80% | $70 → $90 | Upgrade | Neutral → Buy | Get Alert |
| 03/03/2023 | Buy Now | 49% | Piper Sandler | David Westenberg59% | $50 → $70 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | 61.77% | Cowen & Co. | Dan Brennan66% | $56 → $76 | Maintains | Outperform | Get Alert |
| 02/22/2023 | Buy Now | 95.83% | Baird | Catherine Schulte68% | $89 → $92 | Maintains | Outperform | Get Alert |
| 02/22/2023 | Buy Now | 70.29% | BTIG | Mark Massaro72% | $85 → $80 | Maintains | Buy | Get Alert |
| 02/22/2023 | Buy Now | 59.64% | Canaccord Genuity | Kyle Mikson34% | $70 → $75 | Maintains | Buy | Get Alert |
| 02/22/2023 | Buy Now | 49% | Citigroup | Patrick Donnelly80% | $35 → $70 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | 49% | Credit Suisse | Dan Leonard55% | → $70 | Reiterates | → Neutral | Get Alert |
| 02/10/2023 | Buy Now | 49% | Credit Suisse | Dan Leonard55% | $50 → $70 | Downgrade | Outperform → Neutral | Get Alert |
| 01/18/2023 | Buy Now | — | Raymond James | Andrew Cooper54% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/12/2023 | Buy Now | 59.64% | SVB Leerink | Puneet Souda56% | $70 → $75 | Maintains | Outperform | Get Alert |
| 01/06/2023 | Buy Now | 49% | SVB Leerink | Puneet Souda56% | $60 → $70 | Maintains | Outperform | Get Alert |
| 12/16/2022 | Buy Now | 49% | Jefferies | Brandon Couillard71% | → $70 | Maintains | Buy | Get Alert |
| 11/14/2022 | Buy Now | 6.43% | Piper Sandler | David Westenberg59% | $40 → $50 | Maintains | Neutral | Get Alert |
| 11/08/2022 | Buy Now | 27.71% | Raymond James | Andrew Cooper54% | $70 → $60 | Maintains | Outperform | Get Alert |
| 11/07/2022 | Buy Now | 38.36% | BTIG | Mark Massaro72% | $70 → $65 | Maintains | Buy | Get Alert |
| 10/19/2022 | Buy Now | — | Craig-Hallum | Alexander Nowak64% | — | Downgrade | Buy → Hold | Get Alert |
| 08/25/2022 | Buy Now | 17.07% | Credit Suisse | Dan Leonard55% | → $55 | Initiates | → Outperform | Get Alert |
| 08/17/2022 | Buy Now | -14.86% | Piper Sandler | David Westenberg59% | $50 → $40 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | 27.71% | Craig-Hallum | Alex Nowark61% | $81 → $60 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | 42.61% | Cowen & Co. | Dan Brennan66% | $83 → $67 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 49% | BTIG | Mark Massaro72% | $100 → $70 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | 59.64% | Baird | Catherine Ramsey58% | $90 → $75 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 6.43% | Citigroup | Patrick Donnelly80% | $65 → $50 | Maintains | Neutral | Get Alert |
| 08/03/2022 | Buy Now | 49% | Raymond James | Andrew Cooper54% | $80 → $70 | Maintains | Outperform | Get Alert |
| 06/03/2022 | Buy Now | 6.43% | Piper Sandler | David Westenberg59% | → $50 | Initiates | → Neutral | Get Alert |
| 04/27/2022 | Buy Now | 102.21% | B of A Securities | Derik De Bruin84% | $105 → $95 | Maintains | Buy | Get Alert |
| 04/27/2022 | Buy Now | 70.29% | Raymond James | Andrew Cooper54% | $90 → $80 | Maintains | Outperform | Get Alert |
| 04/27/2022 | Buy Now | 102.21% | SVB Leerink | Puneet Souda56% | $130 → $95 | Maintains | Outperform | Get Alert |
| 04/19/2022 | Buy Now | 80.93% | Goldman Sachs | Matthew Sykes66% | $100 → $85 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Exact Sciences (EXAS) stock?
The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by RBC Capital on March 13, 2025. The analyst firm set a price target for $52.00 expecting EXAS to rise to within 12 months (a possible 10.69% upside). 40 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exact Sciences (EXAS)?
The latest analyst rating for Exact Sciences (NASDAQ:EXAS) was provided by RBC Capital, and Exact Sciences initiated their sector perform rating.
When was the last upgrade for Exact Sciences (EXAS)?
The last upgrade for Exact Sciences Corp happened on January 2, 2024 when Benchmark raised their price target to $91. Benchmark previously had a hold for Exact Sciences Corp.
When was the last downgrade for Exact Sciences (EXAS)?
The last downgrade for Exact Sciences Corp happened on August 2, 2023 when Benchmark changed their price target from N/A to N/A for Exact Sciences Corp.
When is the next analyst rating going to be posted or updated for Exact Sciences (EXAS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exact Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exact Sciences was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating Exact Sciences (EXAS) correct?
While ratings are subjective and will change, the latest Exact Sciences (EXAS) rating was a initiated with a price target of $0.00 to $52.00. The current price Exact Sciences (EXAS) is trading at is $46.98, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.